Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data".

× No keyword cloud information.

12 in total

1. Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs.

Authors: E P van Puijenbroek; A C Egberts; E R Heerdink; H G Leufkens
Journal: Eur J Clin Pharmacol Date: 2000-12 Impact factor: 2.953

2. Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug-drug interactions through the FDA adverse event reporting system.

Authors: Ippazio Cosimo Antonazzo; Elisabetta Poluzzi; Emanuele Forcesi; Francesco Salvo; Antoine Pariente; Giulio Marchesini; Fabrizio De Ponti; Emanuel Raschi
Journal: Acta Diabetol Date: 2019-06-15 Impact factor: 4.280

3. A missed protective drug-drug interaction of DPP-4 inhibitors and statins on myopathy risk.

Authors: Oliver Kuss; Wolfgang Rathmann
Journal: Acta Diabetol Date: 2019-11-06 Impact factor: 4.280

4. Comparison of Signal Detection Algorithms Based on Frequency Statistical Model for Drug-Drug Interaction Using Spontaneous Reporting Systems.

Authors: Yoshihiro Noguchi; Tomoya Tachi; Hitomi Teramachi
Journal: Pharm Res Date: 2020-04-30 Impact factor: 4.200

5. Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source.

Authors: Yoshihiro Noguchi; Tomoya Tachi; Hitomi Teramachi
Journal: Brief Bioinform Date: 2021-11-05 Impact factor: 11.622

6. Authors' Reply to Noguchi's comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data."

Authors: John-Michael Gamble; Wajd Alkabbani
Journal: Drug Saf Date: 2022-06-17 Impact factor: 5.228

1. Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)".

Authors: Daniel C Malone; Lorenzo Villa-Zapata; Ainhoa Gómez-Lumbreras; John Horn; Malinda S Tan; Richard D Boyce
Journal: Drug Saf Date: 2022-10-12 Impact factor: 5.228

1 in total

Comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data".